VOYA Investment Management
ATXS

VOYA Investment Management’s Astria Therapeutics ATXS Stock Holding History

VOYA Investment Management’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,590
Closed -$179K – 2415
2025
Q3 		$179K Sell
24,590
-5,458
-18% -$36.9K ﹤0.01% 2208
2025
Q2 		$161K Sell
30,048
-41,220
-58% -$200K ﹤0.01% 2373
2025
Q1 		$381K Sell
71,268
-440
-0.6% -$3.08K ﹤0.01% 1999
2024
Q4 		$641K Buy
71,708
+56,366
+367% +$599K ﹤0.01% 1832
2024
Q3 		$169K Sell
15,342
-432
-3% -$4.8K ﹤0.01% 2532
2024
Q2 		$144K Hold
15,774
– – ﹤0.01% 2570
2024
Q1 		$222K Buy
15,774
+2,147
+16% +$26.7K ﹤0.01% 2405
2023
Q4 		$105K Buy
13,627
+3,192
+31% +$17.6K ﹤0.01% 2748
2023
Q3 		$77.8K Hold
10,435
– – ﹤0.01% 2786
2023
Q2 		$86.9K Buy
+10,435
New +$120K ﹤0.01% 2826

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VOYA Investment Management's ATXS Position: Q4 2025 in Review

VOYA Investment Management sold out of Astria Therapeutics (ATXS) in Q4 2025, closing a stake of 24,590 shares — an estimated $179K sold.

VOYA Investment Management first reported a position in ATXS in Q2 2023 and held it in 10 quarters. The position peaked at $641K in Q4 2024. 141 funds tracked by Wall St. Rank hold ATXS as of Q4 2025.

  • VOYA Investment Management reported no remaining Astria Therapeutics position as of Q4 2025 after selling out during the quarter.
  • VOYA Investment Management sold 24,590 Astria Therapeutics shares in Q4 2025, an estimated $179K.
  • VOYA Investment Management first reported a position in Astria Therapeutics in Q2 2023 and held it in 10 quarters.
  • VOYA Investment Management's Astria Therapeutics position peaked at $641K in Q4 2024.
  • 141 funds tracked by Wall St. Rank held Astria Therapeutics as of Q4 2025.

Based on VOYA Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.